Hjem › Nevroendokrin karsinom › Texas › Houston
Kliniske studier for Nevroendokrin karsinom i Houston, TX
6 studier for Nevroendokrin karsinom søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
RekruttererFase 1
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
RekruttererFase 1
- MD Anderson Cancer Center, Houston
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RekruttererFase 1/2
- Crinetics Study Site, Houston
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RekruttererFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
- Oncology Consultants, PA- Houston, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RekruttererFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Nevroendokrin karsinom-studier i andre byer
- New York City, NY6 studier
- Arlington, VA5 studier
- Dallas, TX4 studier
- Los Angeles, CA4 studier
- Washington, DC4 studier
- St. Louis, MO3 studier
- Columbus, OH3 studier
- Grand Rapids, MI3 studier
- New Haven, CT3 studier
- Atlanta, GA3 studier
- Denver, CO3 studier
- Nashville, TN3 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.